Aripiprazole Augmentation Of Clomipramine Therapy In Treatment-Resistant Obsessive-Compulsive Disorder: Case Series

2016-03-25T20-21-33Z
Source: Düşünen Adam: The Journal of Psychiatry and Neurological Sciences
Filiz İzci, Murat Yalçın, Sümeyye Yasemin Kurtuluş Çallı, Yağmur Sever, Rabia Bilici.
Obsessive-compulsive disorder (OCD) is a chronic disorder characterised by recurrent intrusive thoughts and repetitive rituals, causing significant distress and functional loss. Studies show evidence about serotonergic and dopaminergic mechanisms in neuropathogenesis of OCD. Selective serotonin re-uptake inhibitors (SSRI) are considered first line treatment in OCDs but treatment resistance may occur in 40-60% of cases treated with SSRIs. Augmentation of antidepressants with atypical antipsychotics is an important treatment option in treatment-resistant patients with OCD. In this article, we aimed to present five OCD cases with treatment-resistance in which we obtained good outcomes, with addition of aripiprazole 10-30 mg per day to clomipramine therapy.


from Scope via xlomafota13 on Inoreader http://ift.tt/1US4FRd
via IFTTT